Yoshihiko Sato

Yoshihiko Sato

Auto-generated profile, based on publicly available information

Yoshihiko Sato

Ushio Inc. (Japan)

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2006 in Genetic Resources and Crop Evolution
Verified
Journal Article
Closed access
PDF file
DXD. H. Xu
D. H. Xu
SWS. Wahyuni
S. Wahyuni
YSY. Sato
Y. Sato
MYMomoka Yamaguchi
Momoka Yamaguchi
HTH. Tsunematsu
H. Tsunematsu
TBTomohiro Ban
Tomohiro Ban

1 January 2011 in Endocrine Journal
Verified
Journal Article
Open access
PDF file
HIHiroaki Ishii
Hiroaki Ishii
YSYoshihiko Sato
Yoshihiko Sato
MTMasahiro Takei
Masahiro Takei
SNShinichi Nishio
Shinichi Nishio
MKMitsuhisa Komatsu
Mitsuhisa Komatsu
Pancreatic beta cell dysfunction is pivotal to the development of diabetes, and restoration of insulin action is of primary importance. Here, we present a review of the mechanism of insulin secretion by pancreatic beta cells and discuss the mutual interaction of signaling pathways in stimulus - secretion coupling to better understand the scientific basis of pharmacological treatment for insulin secretion deficiency. Glucose stimulates insulin secretion via membrane depolarization by closure of ATP-sensitive K+ channels (KATP channels) and opening of L-type voltage-dependent Ca2+ channels. The resultant elevation of cytosolic free Ca2+ triggers insulin exocytosis. This is termed the “KATP-dependent pathway” and is shared by sulfonylurea, which closes KATP channels. Glucose also stimulates insulin release independent of its action on KATP channels. This is referred to as the “KATP-independent pathway,” the molecular basis of which remains elusive. In the pancreatic beta cell, incretin hormones increase cAMP level, which enhances glucose-stimulated insulin release by protein kinase A-dependent and -independent mechanisms. Importantly, cAMP does not directly augment Ca2+-stimulated insulin release per se. The stimulatory level of ambient glucose is an absolute requirement for incretin to enhance insulin release. Therefore, incretin/cAMP enhances KATP-independent insulinotropic action of glucose. The robust glucose-lowering effect of DPP4 inhibitor add-on in diabetic patients with sulfonylurea secondary failure is intriguing. With the clinical availability of DPP4 inhibitor and GLP-1 mimetics, the importance of the interactions between cAMP signaling and KATP channel-independent actions of glucose is reappraised.

1 February 2002 in Diabetes
Verified
Journal Article
Open access
PDF file
MKMitsuhisa Komatsu
Mitsuhisa Komatsu
YSYoshihiko Sato
Yoshihiko Sato
SYSatoko Yamada
Satoko Yamada
KYKeishi Yamauchi
Keishi Yamauchi
KHKiyoshi Hashizume
Kiyoshi Hashizume
TAToru Aizawa
Toru Aizawa
Nutrient augmentation of Ca2+-triggered insulin release occurs in an ATP-sensitive K+ (KATP) channel–independent manner. Here, using rat islets, we explored the possibility of the KATP channel-independent nutrient triggering of insulin release. In the presence of 250 μmol/l diazoxide, simultaneous application of forskolin and 16.7 mmol/l glucose strongly stimulated insulin release: fourfold and eightfold increases with 1 and 30 μmol/l forskolin, respectively. α-Ketoisocaproate (KIC) and 3-isobutylmethylxanthine (IBMX) could be used in place of glucose and forskolin, respectively, to trigger insulin release in the presence of diazoxide. Triggering of insulin release by a combination of nutrients and forskolin was not attenuated by 10 μmol/l nifedipine (a blocker of voltage-dependent Ca2+ channels) and 2 μmol/l thapsigargin (an inhibitor of intracellular Ca2+-ATPase), ascertaining independence of this phenomenon from Ca2+ entry and from intracellular Ca2+ liberation. As anticipated, the action of glucose and KIC was greatly (>80%) suppressed by inhibition of mitochondrial metabolism by 2 mmol/l sodium azide (NaN3). A combination of palmitate and dimethyl glutamate (a cell-permeable glutamate donor), but not either one alone, weakly but unequivocally triggered insulin release when applied simultaneously with forskolin. In this case, however, mitochondrial poisoning by azide was without effect. The finding suggests that a combination of induced palmitoylation and cytosolic glutamate accumulation partially reconstituted signaling beyond mitochondrial metabolism in the β-cell upon glucose stimulation. In conclusion, a combination of cAMP signal and nutrients potently triggers insulin release under full activation of the KATP channel, indicating the multiplicity of driving force for insulin exocytosis.

1 January 1993 in Ikushugaku zasshi
Verified
Journal Article
Open access
KAKazuyuki Abe
Kazuyuki Abe
YSYoshihiko Sato
Yoshihiko Sato
TSToshhiro Saito
Toshhiro Saito
AKAkio Kurihara
Akio Kurihara
KKKazuo Kotobuki
Kazuo Kotobuki

1 January 2007 in Engei gakkai zasshi (Journal of the Japanese Society for Horticultural Science)
Verified
Journal Article
Open access
NMNobuko Mase
Nobuko Mase
HIHiroyuki Iketani
Hiroyuki Iketani
YSYoshihiko Sato
Yoshihiko Sato

3 August 2014 in Case Reports in Endocrinology
Verified
Journal Article
Open access
PDF file
MTMasahiro Takei
Masahiro Takei
HIHiroaki Ishii
Hiroaki Ishii
YSYoshihiko Sato
Yoshihiko Sato
MKMitsuhisa Komatsu
Mitsuhisa Komatsu
We herein describe a case of Marine-Lenhart syndrome with a negative TSH receptor antibody titer. A 75-year-old female presented to our hospital with malaise, palpitations, and mild fine tremors. She did not have any signs suggestive of Graves’ ophthalmopathy, including conjunctival injection, periorbital edema, or proptosis. Her laboratory data were negative for thyroid autoantibodies, including anti-thyroid peroxidase antibodies, anti-thyroglobulin antibodies, and anti-TSH receptor antibodies (TRAb). Ultrasonography of the thyroid gland revealed a tumor in the right lobe. The remaining thyroid gland had an inhomogeneous and rough texture with a high color Doppler flow. I123scintigraphy disclosed a hot nodule in the right thyroid gland corresponding to the tumor detected on ultrasonography, suggesting Plummer disease. Furthermore, there was an increased uptake of radionuclide in the rest of the thyroid gland, despite the suppressed level of TSH and negative titer of TRAb, suggesting underlying Graves’ disease. The present findings suggested a diagnosis of Marine-Lenhart syndrome with a negative TRAb titer. Treatment with 10 mCi of radioiodine was highly effective in treating hyperthyroidism in this case. A negative TSH receptor antibody titer does not necessarily rule out the existence of Graves’ disease in patients with Plummer disease.